Review




Structured Review

Myriad Genetics endopredict test
Endopredict Test, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pm36831644-204-0-4
Average 90 stars, based on 1 article reviews
endopredict test - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing.
Article Snippet: Purpose Genomic tests improve accuracy of risk prediction for early breast cancers but these are expensive.. This study evaluated the clinical utility of EndoPredict®, in terms of impact on adjuvant therapy recommendations and identification of parameters to guide selective application.. Methods Patients with ER-positive, HER2-negative, and early-stage invasive breast cancer were tested with EndoPredict®.

Article Title: Classic and New Markers in Diagnostics and Classification of Breast Cancer
Article Snippet: The EndoPredict test ® (Myriad Genetics, Inc.) is used to predict the risk of distant recurrence of early stages (stage I-II), ER/PR-positive, HER2-negative BCs that is either node-negative or has up to three positive lymph nodes [ ].

Article Title: Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer.
Article Snippet: EndoPredict Test, offered by Myriad Genetics, Inc. and available in the US since 2017, is a genomic test for newly diagnosed patients with early-stage, ER-positive, HER2-negative breast cancer (lymph node-negative or node-positive (1–3 nodes), pre- or postmenopausal).

Article Title: Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
Article Snippet: The EndoPredict Test (provided by Myriad Genetics, Inc., Salt Lake City, UT, USA), is another genomic test utilized for patients with newly diagnosed, early-stage (node negative), ER-positive and HER2-negative breast cancer.

Adjuvant:

Article Title: Physicians’ Perceptions of and Satisfaction With Artificial Intelligence in Cancer Treatment: A Clinical Decision Support System Experience and Implications for Low-Middle–Income Countries
Article Snippet: .. In a separate study that focused on adjuvant systemic therapy for breast carcinoma, treatment decisions were changed for 4 of 11 patients after the MDT reviewed WfO’s recommendations and EndoPredict (Myriad Genetics Inc) test reports [ ]. ..



Similar Products

90
Sividon Diagnostics GmbH endopredict test
Endopredict Test, supplied by Sividon Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pm39406507-413-1-4
Average 90 stars, based on 1 article reviews
endopredict test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Myriad Genetics endopredict test
Endopredict Test, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pm36831644-204-0-4
Average 90 stars, based on 1 article reviews
endopredict test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Myriad Genetics endopredict® testing
Endopredict® Testing, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pm34853987-158-0-0
Average 90 stars, based on 1 article reviews
endopredict® testing - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Myriad Genetics endopredict tests
Endopredict Tests, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/10__1016_slash_j__annonc__2021__02__003-26-2-0
Average 90 stars, based on 1 article reviews
endopredict tests - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Myriad Genetics endopredict® test
Endopredict® Test, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pm31869667-281-13-6
Average 90 stars, based on 1 article reviews
endopredict® test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Myriad International GmbH endopredict test
Flowchart demonstrating <t>EndoPredict</t> test results and final tumor board recommendations
Endopredict Test, supplied by Myriad International GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict+test/pmc07584549-47-11-14
Average 90 stars, based on 1 article reviews
endopredict test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Myriad Genetics breast cancer recurrence test endopredict
Flowchart demonstrating <t>EndoPredict</t> test results and final tumor board recommendations
Breast Cancer Recurrence Test Endopredict, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/endopredict+test/endopredict/10__1245_slash_s10434___020___08630___3-4780-4-11
Average 90 stars, based on 1 article reviews
breast cancer recurrence test endopredict - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Flowchart demonstrating EndoPredict test results and final tumor board recommendations

Journal: Archives of Gynecology and Obstetrics

Article Title: First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer

doi: 10.1007/s00404-020-05771-4

Figure Lengend Snippet: Flowchart demonstrating EndoPredict test results and final tumor board recommendations

Article Snippet: One of these widely used commercially available genomic assays is the EndoPredict ® test (Myriad International GmbH, Cologne, Germany).

Techniques: